Compound ID | 703
Class: Peptide deformylase inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Use against CAP and Anthrax |
Institute where first reported: | Vernalis |
Year first mentioned: | 2002 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Resistance development (LS) |
External links: | |
Citation: | https://www.sciencedirect.com/science/article/pii/S0924857903002462 |